Literature DB >> 8245551

Comparability and reliability of ELISA, immunofluorescence, and indirect hemagglutination assays for Trypanosoma cruzi and Trypanosoma rangeli.

A Ross1, D Novoa-Montero.   

Abstract

Serum samples and filter paper spot samples from 48 adults were assayed in three laboratories for Trypanosoma cruzi and Trypanosoma rangeli by ELISA, immunofluorescence (IF), and indirect hemagglutination (HA) in a controlled, blind experiment. IF (serum samples) attained higher levels of comparability necessary for validity than did ELISA (serum samples) in these laboratories. ELISA was inferior to IF and HA (spot samples) in testing for T. cruzi. ELISA was not reliable (intrasubject r = .51) and was not in agreement between two laboratories (kappa = .09). The experiment indicates that ELISA is not the best choice of assay for T. cruzi in epidemiologic surveys. Assays for T. rangeli by ELISA and IF lacked comparability to the extent that those two techniques could not be considered useful for T. rangeli.

Entities:  

Mesh:

Year:  1993        PMID: 8245551     DOI: 10.1093/infdis/168.6.1581

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits.

Authors:  D A Leiby; S Wendel; D T Takaoka; R M Fachini; L C Oliveira; M A Tibbals
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Profile of Trypanosoma cruzi reactivity in a population at high risk for endemic pemphigus foliaceus (Fogo selvagem).

Authors:  Joaquim X Sousa; Luis A Diaz; Donald P Eaton; Günter Hans-Filho; Elder Lanzani de Freitas; Livia Delgado; Ligia Maria F Ichimura; Flávia Cristaldi; Renata Orlandi; Norival Kesper; Eufrosina S Umezawa; Evandro A Rivitti; Valeria Aoki
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

3.  Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.

Authors:  N Gironès; C I Rodríguez; B Basso; J M Bellon; S Resino; M A Muñoz-Fernández; S Gea; E Moretti; M Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection.

Authors:  Taciana de Souza Bayão; Marli do Carmo Cupertino; Nicholas Alfred Joseph Mayers; Rodrigo Siqueira-Batista
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.